Health Catalyst, Inc.
- Stock
- Ticker HCAT
- ISIN US42225T1079
- Nasdaq
Performance, volatility and drawdowns of Health Catalyst, Inc. since 07/2019, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $249. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −98.3% in 04/2026, measured from the peak in 06/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 80 | 79 | 81 | 76 | 75 | 71 | 70 | 56 |
| Gross profit | – | – | – | 40 | – | – | – | – |
| Operating income | -18 | -20 | -37 | -18 | -86 | -106 | -36 | 50 |
| EBITDA | -7.2 | -7.9 | -24 | -4.9 | -73 | -94 | -26 | 60 |
| Net income | -21 | -24 | -41 | -22 | -91 | -111 | -41 | 40 |
| Earnings per share | -0.33 | -0.35 | -0.59 | -0.32 | -1.30 | -1.53 | -0.55 | 0.53 |
| Balance sheet | ||||||||
| Total assets | 859 | 892 | 616 | 587 | 503 | 412 | 359 | 237 |
| Liabilities | 494 | 515 | 269 | 255 | 257 | 274 | 258 | 92 |
| Equity | 365 | 377 | 348 | 332 | 246 | 138 | 101 | 146 |
| Cash | 250 | 342 | 51 | 40 | 51 | 60 | 61 | 54 |
| Long-term debt | 151 | 151 | 151 | 152 | 152 | 152 | 152 | 0.0 |
| Cash flow | ||||||||
| Operating cash flow | -3.5 | 0.3 | -9.0 | -0.5 | 9.9 | 19 | 0.3 | -1.9 |
| Capital expenditure | -0.4 | -0.7 | 0.2 | -0.3 | -0.3 | -0.3 | -0.3 | -0.2 |
| Free cash flow | -3.9 | -0.4 | -8.8 | -0.7 | 9.6 | 18 | -0.1 | -2.0 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2020 at +25.4%, weakest 2022 at −73.2%. 1 of 6 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 5 Nov 2026 | $0.53 |
| 6 Aug 2026 | −$0.55 |
| 11 May 2026 | −$1.53 |
| 12 Mar 2026 | −$1.30 |
| 10 Nov 2025 | −$0.32 |
| 8 Aug 2025 | −$0.59 |
| 9 May 2025 | −$0.35 |
| 26 Feb 2025 | −$0.33 |
| 7 Nov 2024 | −$0.24 |
| 8 Aug 2024 | −$0.23 |
| 10 May 2024 | −$0.35 |
| 22 Feb 2024 | −$0.52 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €90m
- Market cap in trading currency
- $99.8m
- Enterprise value
- $20.8m
- P/E
- –
- P/S
- 0.37
- P/B
- 0.69
- EV/Sales
- 0.08
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- 25.8%
Results (last four quarters)
- Revenue
- $272m
- Gross profit
- –
- EBITDA
- −$133m
- Net income
- −$202m
- Earnings per share
- −$2.85
- Revenue per share
- $3.57
- Revenue growth
- −26.3%
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- -65.7%
- Net margin
- -74.2%
- Return on equity
- -84.6%
- Return on assets
- -85.1%
Balance sheet and cash flow
- Cash
- $79.0m
- Cash per share
- $1.04
- Financial debt
- $0
- Debt/equity %
- 0
- Current ratio
- 1.70
- Book value per share
- $1.91
- Operating cash flow
- $26.8m
- Free cash flow
- $25.7m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 76.2m
- Volume
- 711,625
- Avg. volume 3 months
- 435,054
- Relative volume
- 1.7
Price and technicals
- Price
- $1.31
- 1 day
- +1.6%
- 52-week high
- $2.99
- 52-week low
- $1.00
- Distance to 52-week high
- −56.2%
- Distance to 52-week low
- +31.5%
- Distance to 50-day line
- −20.7%
- Distance to 200-day line
- −20.9%
- RSI (14)
- 37
- Volatility 1M
- 99.0%
Performance
- 1 week
- −13.2%
- 1 month
- −24.7%
- 3 months
- −17.6%
- 6 months
- +1.6%
- YTD
- −45.2%
- 1 year
- −37.9%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has HCAT performed since 07/2019?
$10,000 grew to $334 by 20 Nov 2026, which is −37.1% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is HCAT?
Volatility was 51.3% per year, measured on monthly returns. The largest decline from a peak was −98.3%, with the low in 04/2026.
How does HCAT compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.1% per year at 16.2% volatility, HCAT returned −37.1% at 51.3%. The correlation of monthly returns was 0.43; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.